Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients

Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: یاسر خواجه بیشک , حامد همیشه کار , محمدرضا علی وند , مهدیه علیپور , بیت الله علیپور

کلمات کلیدی: Lipid profile, Cytokines, Pomegranate seed oil, PPAR-c, Punicic acid, Type 2 diabetes

نشریه: 25875 , 0 , 0 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله یاسر خواجه بیشک
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده تغذیه
کد مقاله 66402
عنوان فارسی مقاله Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients
عنوان لاتین مقاله Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Purpose Diabetes is one of the most prevailed chronic diseases in the world. Pro-inflammatory cytokines play a key role in the type 2 diabetes mellitus. Pomegranate seed oil (PSO) has potential anti-inflammatory properties. The purpose of this study is to evaluate the antidiabetic effects of the use of PSO on the expression of peroxisome proliferator-activated receptor-gamma (PPAR-γ), pro-inflammatory biomarkers and lipid profile levels in obese type 2 diabetic patients. Design/methodology/approach In total, 52 patients were randomly assigned to the PSO (n = 26) and placebo (n = 26) groups. Subjects received daily PSO 3 g placebo (paraffin) in 1 g soft-gel capsules (along with breakfast, lunch and dinner meals) for eight weeks. Findings Serum levels of fasting blood sugar (FBS) decreased from 161.46 ± 34.44 to 143.50 ± 24.2 mg/dL (p = 0.008), IL-6 decreased from 5.17 ± 2.25 to 4.52 ± 1.90 (p = 0.049) and tumor necrosis factor alpha (TNF-a) significantly decreased from 9.17 6 4.13 to 7.74 6 2.44 pmol/mL in PSO group (p = 0.030). However, changes in the expression of PPAR-g gene, serum levels of hs-CRP and lipid profile levels were not significant. Research limitations/implications – Lack of PSO concentration measurements and the short duration of the study were the key limitations. Future randomized clinical trials with a longer period of follow-up are needed to assess the potential anti-diabetic effects of PSO. Originality/value – Administration of PSO in obese type 2 diabetic patients reduced the levels of FBS,interleukin6andTNF-a; nevertheless, changes in the insulin, lipid profiles and hs-CRP were not significant.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
یاسر خواجه بیشکاول
حامد همیشه کارسوم
محمدرضا علی وندچهارم
مهدیه علیپورپنجم
بیت الله علیپورهفتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
IMG-20190617-WA0001.jpg1398/03/2828823دانلود
article 2 full.pdf1398/01/26198265دانلود